Regarding the histological features, the majority were intermediate/moderate grade (40.8%), estrogen receptor-positive (74.6%), progesterone receptor-positive (63.1%), stage IV (4.9%) and with a diagnosis of invasive ductal carcinoma (78.4%). This evidence concerns the gene ESR1 and invasive ductal breast carcinoma.